Arin LogoArin
Back

STYRENE OXIDE

Allergen0 products
CAS
96-09-3
EC
2024767
PubChem CID
7276
Molecular Formula
C8H8O
Molecular Weight
120.1500 g/mol

A full English write-up is not available yet. Category and regulatory notes above still apply.

Restrictions

Function & Use

Not Reported

Regulatory note

  • EU 1223/2009 Annex IIProhibited

Industry GHS notices (PubChem)

These are industry self-reports to ECHA, not our regulatory assessment.

  • H227- Combustible liquid
  • H302- Harmful if swallowed
  • H311(15.0%)- Toxic in contact with skin
  • H312(80.7%)- Harmful in contact with skin
  • H315(57.2%)- Causes skin irritation
  • H317(57.0%)- May cause an allergic skin reaction
  • H319(95.7%)- Causes serious eye irritation
  • H331(57.0%)- Toxic if inhaled
  • H332- Harmful if inhaled
  • H336- May cause drowsiness or dizziness
  • H340(42.2%)- May cause genetic defects
  • H341(25.1%)- Suspected of causing genetic defects
  • H350(95.7%)- May cause cancer
  • H361- Suspected of damaging fertility or the unborn child
  • H370- Causes damage to organs
  • H401- Toxic to aquatic life
  • H412- Harmful to aquatic life with long lasting effects
PubChem CID 7276
The verdict isn’t ours: below is what ToxValDB (EPA Toxicity Value Database), SCCS (EU Scientific Committee on Consumer Safety), EPA ToxCast (high-throughput in vitro screening), IARC (International Agency for Research on Cancer) said, verbatim.

What The Sources Say

SCCS (EU Scientific Committee on Consumer Safety)4
Safety assessment

EU 1223/2009 Annex II — SCCS opinion: Mutagenic or Toxic to Reproduction according to the Chemicals Directive 67/548/EECC

Safety assessment

EU 1223/2009 Annex II — SCCS opinion: Opinion concerning Chemical Ingredients in Cosmetic Products classified as Carcinogenic

Safety assessment

EU 1223/2009 Annex II — SCCS opinion: Mutagenic or Toxic to Reproduction according to the Chemicals Directive 67/548/EEC

+1 more records.

IARC (International Agency for Research on Cancer)1
Hazard claimView source →

IARC Group 2A - Probably carcinogenic to humans. Limited evidence in humans, sufficient evidence in experimental animals. (Monograph volume: Sup 7, 60, 121). Caveat: IARC classifies HAZARD, not RISK - it says 'can cause cancer under some conditions', not 'causes cancer at cosmetic use levels'. Route and dose must be assessed separately. Data is a 01/2021 snapshot.

ToxValDB (EPA Toxicity Value Database)10
Hazard claimView source →

EPA ToxValDB skin/eye data — endpoint: Skin Sensitization, classification: Category 1. Caveat: this is an aggregated record; dose, species and route of exposure must be considered together.

Hazard claimView source →

EPA ToxValDB skin/eye data — endpoint: Eye Irritation, classification: Category 6.4A (Category 2A). Caveat: this is an aggregated record; dose, species and route of exposure must be considered together.

Hazard claimView source →

EPA ToxValDB skin/eye data — endpoint: eye irritation: in vivo, classification: Severe Irritation, species: rabbit, study: eye irritation, guideline: OECD Guideline 405 (Acute Eye Irritation / Corrosion) equivalent or similar to, year: 1990. Caveat: this is an aggregated record; dose, species and route of exposure must be considered together.

Hazard claimView source →

EPA ToxValDB kanser değerlendirmesi: 2A - Probably carcinogenic to humans. Caveat: this is an aggregated record; dose, species and route of exposure must be considered together.

Hazard claim

EPA ToxValDB genotoxicity: positive — positive reports: 36, negative: 14, Ames: positive, micronucleus: positive. Caveat: this is an aggregated record; dose, species and route of exposure must be considered together.

+5 more records.

EPA ToxCast (high-throughput in vitro screening)1
Safety assessmentView source →

EPA ToxCast ER model: NO estrogen receptor activity found (AUC agonist=0, antagonist=0). Tested in 18 in vitro assays. Caveat: this is an in vitro screening model with no dose or exposure context; it does NOT mean an effect occurs in humans at cosmetic use levels.

Scientific References